Monoclonal antibodies are quickly
becoming key resources in the therapeutic, diagnostic and drug
discovery fields. With the phenomenal growth in the market for
monoclonal antibodies, it becomes even more critical to
explore diverse methods of design, production and application
of technologies to provide the antibodies needed.
This conference will provide researchers with key
updates on important developments in the monoclonal antibody
field covering generation, optimization, drug discovery
research, and in vivo diagnostics, as well as case
studies of successful mAb science.
Developmental Trends in Antibody
Fragment Therapeutics
Aaron Nelson, M.D.,Tufts University School of Medicine
Unveiling a Glycation Hot Spot in
a Recombinant Humanized Monoclonal Antibody
J. Zhang, Ph.D., Protein Analytical Chemistry, Cell Culture
Development, Purification Development, Protein Chemistry, and
Antibody Engineering, Genentech, Inc. (invited)
Critical Role of Somatic Mutations
in High Potency Human Monoclonal Antibodies to Viruses
James Crowe, M.D., Ingram Professor, Pediatrics and
Microbiology and Immunology, Vanderbilt University Medical
Center
A Novel HPLC-UV-MS Method for
Quantitative Analysis of Protein Glycosylation
Anton S. Karnoup, Ph.D., Analytical Sciences, The Dow
Chemical Company
Accelerating
the Process
Selection of Antibody Producing
Cells by Toxine Conjugates
Katrin Messerschmidt, Ph.D., Biotechnology, University of
Potsdam
Lead Identification and
Optimization in Crude Samples using Label-free Resonant
Acoustic Profiling
Helge Schnerr, Ph.D.,
Product Manager, TTP LabTech, TTP LabTech Ltd.
Case
Studies
Development and Characterization
of Monoclonal Antibodies to Equine Luteinizing Hormone for
Diagnostic Applications
Nathalie Forster, M.S., Product Development and Support
Manager, Research and Development, Maine Biotechnology
Services, Inc.
High Cytotoxic mAb for the
Treatment of FMAI
Margarita Salcedo, Ph.D., Head Scientific Strategy, Medical
and Scientific Affairs, LFB S.A.
Targeting ED-B Fibronectin: Using
BC1-IL12 (AS1409) in Melanoma and Renal Cell Carcinoma
Ben
Doran, M.Sc., Research Scientist, Protein Production, Antisoma
Research Limited
For questions or suggestions about the meeting, please contact:
Elizabeth Lamb
Cambridge Healthtech Institute
Phone: 207-493-7874
email: elamb@healthtech.com
For sponsorship and exhibit information, contact:
Carol Dinerstein
Phone: 781-972-5471
email: dinerstein@healthtech.com
